Dissolution Technologies Company Profile

18:50 EDT 23rd March 2018 | BioPortfolio

This site is a companion to Dissolution Technologies, a quarterly publication reporting relevant information on dissolution testing. It provides an international forum for open exchange of information on various dissolution topics


9 Yorkridge Trail
DE 19707


Phone: 302-235-0621.
Fax: 443-946-1264

News Articles [200 Associated News Articles listed on BioPortfolio]

Notice Of Dissolution Of Engex, Inc. (symbol exgi)

Notice Of Dissolution Of Engex, Inc. (symbol exgi)

Predictive Dissolution Modeling: Next-Generation Development and Release Strategy

Defiant Hun Sen tells U.S. to cut all aid to Cambodia

Cambodian Prime Minister Hun Sen challenged the United States on Sunday to cut all aid after it announced it was ending funding for a general election next year in response to the dissolution of the m...

Optimising process conditions to improve drug delivery characteristics: part II

The impact of extrusion process parameters on drug recovery and the dissolution performance of solid dispersions of Ritonavir and AFFINISOL HPMC HME

Park Place Technologies Acquires Axentel Technologies

The Axentel Technologies acquisition allows Park Place Technologies to significantly enhance its ability to service customers in Singapore, Malaysia, Hong Kong, Thailand Read more...

Park Place Technologies adquiere Axentel Technologies

La adquisición de Axentel Technologies permite a Park Place Technologies mejorar considerablemente su capacidad de prestar servicios a clientes en Singapur, Malasia, Hong Kong, Read more...

Agilent Technologies agrees to acquire Advanced Analytical Technologies

Agilent Technologies Inc. agreed to acquire privately held Advanced Analytical Technologies Inc. (AAT; develops and sells high-throughput, fully-automated nucleic acid analysis systems) for $250mm in ...

BioSpecifics Technologies (BSTC) versus Its Competitors Critical Analysis

BioSpecifics Technologies is one of 286 public companies in the "Bio Therapeutic Drugs" industry, but how does it weigh in compared to its rivals? We will compare BioSpecifics Technologies to related ...

PubMed Articles [514 Associated PubMed Articles listed on BioPortfolio]

Optimization of Dissolution Compartments in a Biorelevant Dissolution Apparatus Golem v2, Supported by Multivariate Analysis.

Biorelevant dissolution instruments represent an important tool for pharmaceutical research and development. These instruments are designed to simulate the dissolution of drug formulations in conditio...

Dry powder inhalers: An overview of the in vitro dissolution methodologies and their correlation with the biopharmaceutical aspects of the drug products.

In vitro dissolution testing is routinely used in the development of pharmaceutical products. Whilst the dissolution testing methods are well established and standardized for oral dosage forms, i.e. t...

Lyophilic matrix method for dissolution and release studies of nanoscale particles.

We introduce a system with a lyophilic matrix to aid dissolution studies of powders and particulate systems. This lyophilic matrix method (LM method) is based on the ability to discriminate between no...

Feasibility of Using Gluconolactone, Trehalose and Hydroxy-Propyl Gamma Cyclodextrin to Enhance Bendroflumethiazide Dissolution Using Lyophilisation and Physical Mixing Techniques.

Hydrophobic drugs are facing a major challenge in dissolution rate enhancement and solubility in aqueous solutions; therefore, a variety of methods have been used to improve dissolution rate and/or so...

Molecular-level elucidation of saccharin-assisted rapid dissolution and high supersaturation level of drug from Eudragit® E solid dispersion.

In this work, the effect of saccharin (SAC) addition on the dissolution and supersaturation level of phenytoin (PHT)/Eudragit® E (EUD-E) solid dispersion (SD) at neutral pH was examined. The PHT/EUD-...

Clinical Trials [377 Associated Clinical Trials listed on BioPortfolio]

Shockwave Lithotripsy (SWL) Versus Oral Dissolution Therapy (ODT) Versus Combined SWL And ODT For Radiolucent Renal Stone

compare the efficacy of of ultrasound guided SWL versus dissolution therapy versus combined SWL and dissolution therapy in management of 1 - 2.5 cm renal stones.

A Study to Assess the Effects of Dissolution Profile on the Pharmacokinetics of Single Oral Doses of Tafenoquine Tablets and Tafenoquine Stable Isotope Labelled Solution

This study will investigate the effect of Tafenoquine (TQ) 150 mg tablet ageing (dissolution profiles) on human exposure of TQ comparing the relative bioavailability of TQ from tablets exh...

Renalof in the Dissolution of Renal Calculi in Patients With Recurrent Calcic Lithiasis

The purpose of this study is to determine whether Renalof administration promotes partial or total dissolution of urinary calculi and improves physicochemical parameters and metabolic acti...

Study Will Evaluate the Relative Bioavailability, Safety, and Tolerability of Single Doses of Nifurtimox 30 mg Tablets Exhibiting Different in Vitro Dissolution Characteristics, and to Evaluate the Relative Bioavailability of Nifurtimox 30 mg and 120 mg

Study to assess the relative Bioavailability To assess the relative bioavailability of three formulations of nifurtimox 30 mg tablets exhibiting different in vitro dissolution profiles To ...

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Companies [1258 Associated Companies listed on BioPortfolio]

Dissolution Technologies

This site is a companion to Dissolution Technologies, a quarterly publication reporting relevant information on dissolution testing. It provides an international forum for open exchange of information...

Argonaut Technologies Inc

The Shareholders have voted for dissolution of the company. The vote was held and completed on March 21, 2011.

Distek, Inc.

In 2005, Distek will celebrate a 25 year tradition of quality and dependability by commemorating the release of our first dissolution tester, the Model 2000. Since our inception, Distek has retained ...

AuraZyme™ Pharmaceuticals

AuraZyme™ Pharmaceuticals is a development stage company founded to develop and commercialize therapeutic drug formulations that increase efficacy of drug therapy, lower drug dosage requirements, re...

pION Inc.

pION, a world leader in drug absorption measurement, specializes in the determination and prediction of solubility, dissolution, permeability and human absorption. pION also offers a range of instrume...

More Information about "Dissolution Technologies" on BioPortfolio

We have published hundreds of Dissolution Technologies news stories on BioPortfolio along with dozens of Dissolution Technologies Clinical Trials and PubMed Articles about Dissolution Technologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dissolution Technologies Companies in our database. You can also find out about relevant Dissolution Technologies Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record